Summit Securities Group’s Core Laboratories CLB Stock Holding History

Summit Securities Group’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,872	Closed	-$31.4K	–	1185
2026 Q1	$31.4K	Buy	+1,872	New	+$33.5K	﹤0.01%	450
2025 Q3	–	Sell	-3,445	Closed	-$39.7K	–	1072
2025 Q2	$39.7K	Buy	+3,445	New	+$40.9K	0.01%	565
2022 Q3	–	Sell	-1	Closed	–	–	955
2022 Q2	$0	Buy	+1	New	+$27	﹤0.01%	978
2016 Q1	–	Sell	-3,175	Closed	-$345K	–	173
2015 Q4	$345K	Buy	+3,175	New	+$363K	0.11%	127
2015 Q3	–	Sell	-1,100	Closed	-$125K	–	386
2015 Q2	$125K	Buy	+1,100	New	+$133K	0.06%	109
2014 Q4	–	Sell	-20	Closed	-$3K	–	623
2014 Q3	$3K	Buy	+20	New	+$3.09K	﹤0.01%	591

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Summit Securities Group's CLB Position: Q2 2026 in Review

Summit Securities Group sold out of Core Laboratories (CLB) in Q2 2026, closing a stake of 1,872 shares — an estimated $31.4K sold.

Summit Securities Group first reported a position in CLB in Q3 2014 and held it in 6 quarters. The position peaked at $345K in Q4 2015. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Summit Securities Group reported no remaining Core Laboratories position as of Q2 2026 after selling out during the quarter.
Summit Securities Group sold 1,872 Core Laboratories shares in Q2 2026, an estimated $31.4K.
Summit Securities Group first reported a position in Core Laboratories in Q3 2014 and held it in 6 quarters.
Summit Securities Group's Core Laboratories position peaked at $345K in Q4 2015.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.